Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

3rd EurocanPlatform Translational Research Course /
Cancer systems biology

12th - 16th Oct 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 22.12.15
Views: 2240

Dr Martin Peifer - University Of Cologne, Cologne, Germany

Dr Peifer discusses what is involved in cancer systems biology, the identification of biologically relevant cancer genome alterations from large-scale sequencing efforts which require a systematic computational data analysis, and his approach to integrate various (epi-) genomic datasets to identify such alterations. He speaks at the 3rd EurocanPlatform Translational Research Course.

He explores examples in small cell lung cancer and neuroblastoma, plus the significance to clinical practice, what the next steps will be, what challenges the work faces and what the eventual benefit will be.

Read Dr Peifer’s Nature papers on neuroblastoma and SCLC

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation